Ligandrol 15mg/tab 50 Tabletten by Rich Piana 5% Nutrition

Usage

1. Establish your target dose range before day one, using bodyweight, training experience, and recent bloodwork as reference points — the 15 mg tablet format accommodates doses from 5 mg (split) to 15 mg (whole tablet).
2. Administer one daily dose at a consistent time, preferably with or shortly after a meal to support gastrointestinal comfort and stable absorption across the 8-week window.
3. Log each dose on a cycle calendar from day one through day 56 (end of week 8); record any subjective changes in strength, recovery, or libido weekly as early suppression markers.
4. At week 4, perform a mid-cycle blood panel measuring total testosterone, LH, and FSH; use results to decide whether to maintain, reduce, or — if adverse signals appear — discontinue the current cycle.
5. On the final day of week 8, cease administration completely; do not attempt to taper the dose, as the compound's half-life manages the exit gradient naturally.
6. Begin your chosen PCT protocol no later than 72 hours post-last dose; run PCT for a minimum of 4 weeks, then retest bloodwork before planning any subsequent SARM cycle.

Warnings

Frequently asked questions

How long should a Ligandrol (LGD-4033) cycle typically run for optimal results?

The widely accepted standard for a Ligandrol cycle is 8 weeks, balancing meaningful anabolic stimulus with a suppression timeline that structured post-cycle therapy can address. Some researchers run as few as 6 weeks for a conservative first exposure. Extending beyond 10 weeks is generally not recommended without advanced bloodwork monitoring, as HPGA suppression deepens with cumulative exposure time.

What dose ranges are most commonly used in an 8-week LGD-4033 protocol?

Entry-level doses in an 8-week LGD-4033 protocol typically start at 2.5–5 mg per day, with intermediate users working in the 5–10 mg range. Advanced bodybuilding contexts have documented use up to 15 mg/day — matching the full tablet strength of this product. Dose selection should be informed by research intent, baseline bloodwork, and individual response during the first two weeks.

How long should the off-period be after completing an 8-week Ligandrol cycle?

A commonly applied guideline is that the off-period should equal at least the cycle length plus PCT duration — meaning roughly 8–12 weeks total before beginning another run. This allows the hypothalamic-pituitary-gonadal axis (HPGA) to restore endogenous testosterone output. Bloodwork confirming normalised LH, FSH, and total testosterone levels provides a more reliable restart signal than time alone.

Why does the 15 mg per tablet concentration of this product matter for structuring a cycle?

The 15 mg/tab strength — the highest in this product format — gives researchers direct access to full advanced-phase doses without combining multiple tablets, while also allowing precise splitting for lower-dose phases. At 10 mg/day across a standard 56-day (8-week) cycle, 50 tablets provide the complete cycle quantity plus a buffer for a dose-ramp entry week. This reduces logistical complexity and cost over the full protocol.

Can a 15 mg LGD-4033 tablet be split to achieve lower doses during the early weeks of a cycle?

Yes — splitting a 15 mg tablet produces two approximately 7.5 mg portions, which falls within the intermediate dosing range and is suitable for weeks one and two of a gradual dose-escalation protocol. Because each tablet's potency is confirmed via HPLC chromatography before release, the compound is uniformly distributed, making tablet splitting a practical and consistent option for researchers calibrating their entry dose. (2) angle_used

Manufacturer

Rich Piana 5% Nutrition applies a two-stage laboratory verification framework to its research compound tablets — potency first, safety second, with neither step optional. For this Ligandrol product, HPLC (High-Performance Liquid Chromatography) quantitative analysis is performed at batch level: chromatographic retention time and peak area confirm that LGD-4033 content per tablet meets the declared 15 mg specification within established analytical tolerances before any unit enters packaging. A separate microbiological safety assessment using the LAL (Limulus Amebocyte Lysate) method detects bacterial endotoxin load in the finished batch, providing a bioburden checkpoint independent of the potency result. This sequential, instrument-driven verification sequence — rather than reliance on supplier certificates of analysis alone — defines how 5% Nutrition positions quality control within its compound research line.